Brain Neoplasms

"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Descriptor ID	D001932
MeSH Number(s)	C04.588.614.250.195 C10.228.140.211 C10.551.240.250
Concept/Terms	Brain Neoplasms Brain Neoplasms Neoplasms, Brain Brain Neoplasm Neoplasm, Brain Brain Tumors Brain Tumor Tumor, Brain Tumors, Brain Brain Cancer Brain Cancer Brain Cancers Cancer, Brain Cancers, Brain Malignant Neoplasms, Brain Brain Malignant Neoplasm Brain Malignant Neoplasms Malignant Neoplasm, Brain Cancer of Brain Cancer of the Brain Neoplasms, Brain, Malignant Brain Neoplasms, Malignant Brain Neoplasm, Malignant Malignant Brain Neoplasm Malignant Brain Neoplasms Neoplasms, Intracranial Neoplasms, Intracranial Intracranial Neoplasm Neoplasm, Intracranial Intracranial Neoplasms Brain Tumor, Recurrent Brain Tumor, Recurrent Brain Tumors, Recurrent Recurrent Brain Tumor Recurrent Brain Tumors Malignant Primary Brain Tumors Malignant Primary Brain Tumors Primary Malignant Brain Tumors Malignant Primary Brain Neoplasms Primary Malignant Brain Neoplasms Brain Neoplasms, Malignant, Primary Brain Neoplasms, Primary Malignant Benign Neoplasms, Brain Benign Neoplasms, Brain Benign Neoplasm, Brain Brain Benign Neoplasm Brain Benign Neoplasms Neoplasms, Brain, Benign Brain Neoplasms, Benign Benign Brain Neoplasm Benign Brain Neoplasms Brain Neoplasm, Benign Brain Tumor, Primary Brain Tumor, Primary Brain Tumors, Primary Primary Brain Tumor Primary Brain Tumors Neoplasms, Brain, Primary Brain Neoplasm, Primary Brain Neoplasms, Primary Primary Brain Neoplasm Primary Brain Neoplasms

Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Nervous System Neoplasms [C04.588.614]
Central Nervous System Neoplasms [C04.588.614.250]
Brain Neoplasms [C04.588.614.250.195]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Brain Neoplasms [C10.228.140.211]
Nervous System Neoplasms [C10.551]
Central Nervous System Neoplasms [C10.551.240]
Brain Neoplasms [C10.551.240.250]

Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.

Bar chart showing 273 publications over 30 distinct years, with a maximum of 23 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	2	4
1998	4	2	6
1999	2	1	3
2000	6	1	7
2001	7	0	7
2002	6	0	6
2003	4	0	4
2004	6	2	8
2005	10	3	13
2006	4	1	5
2007	8	3	11
2008	6	1	7
2009	5	1	6
2010	12	1	13
2011	9	4	13
2012	14	0	14
2013	2	1	3
2014	13	1	14
2015	21	2	23
2016	8	2	10
2017	14	3	17
2018	10	1	11
2019	7	1	8
2020	13	2	15
2021	11	2	13
2022	8	0	8
2023	4	0	4
2024	12	0	12
2025	5	0	5
2026	3	0	3

Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.

Tringale KR, Jenabi M, Kohli J, Jackson C, Hattangadi-Gluth JA, McDonald CR, Fahy T, Ramjan S, Sands S, Holodny A, Wolden SL, Vachha BA. Functional neuroimaging biomarkers of impaired neurocognition after proton beam radiotherapy for brain tumors in pediatric patients: A prospective trial. Neuro Oncol. 2026 Jul 01; 28(7):1794-1807.

View in: PubMed
Willis KD, Forst DA, Horick N, Strander SM, Whitman J, Corveleyn A, Sannes T, Temel JS, Greer JA, El-Jawahri A, Jacobs JM. Improved coping and self-efficacy drive improvements in mood among caregivers of patients with primary malignant brain tumors: Results from a randomized controlled trial. Neuro Oncol. 2026 Jul 01; 28(7):1741-1752.

View in: PubMed
Falc?-Roget J, Basile GA, Janus A, Lillo S, Politi LS, Argasinski JK, Cacciola A. A non-local diffusion magnetic resonance imaging tract density biomarker to stratify, predict, and interpret survival rates in human glioblastoma. Neuro Oncol. 2026 Feb 01; 28(2):564-579.

View in: PubMed
Jeung YS, Lee WT, Kim Y, Keam B, Kim TM, Park CK, Sim JA, Yoo SH. Documented advance care planning elements and end-of-life care patterns in malignant glioma vs. major solid tumors: a single-center retrospective study. J Neurooncol. 2025 Dec 29; 176(2):142.

View in: PubMed
Giovannoni F, Strathdee CA, Faust Akl C, Andersen BM, Li Z, Lee HG, Torti MF, Rone JM, Duart-Abadia P, Molgora M, Kong L, Floyd M, Teng J, Gyulakian Y, Grzesik P, Farkaly T, Denslow A, Feau S, Rodriguez-Sanchez I, Jacques J, Colonna M, Kennedy EM, Cheema T, Lerner L, Qu?va C, Quintana FJ. Retargeted oncolytic viruses engineered to remodel the tumor microenvironment for glioblastoma immunotherapy. Nat Cancer. 2025 Dec; 6(12):1994-2010.

View in: PubMed
Tamborini M, Ribecco V, Stanzani E, Sironi A, Tambalo M, Franzone D, Florio E, Fraviga E, Saulle C, Gagliani MC, Pizzocri M, Mattioli M, Cortese K, Jiang JX, Martano G, Politi LS, Riva M, Pessina F, Pozzi D, Lodato S, Passoni L, Matteoli M. Extracellular vesicles released by glioblastoma cancer cells drive tumor invasiveness via Connexin-43 gap junctions. Neuro Oncol. 2025 Nov 01; 27(11):2843-2860.

View in: PubMed
Ressa G, Levi R, Savini G, Raspagliesi L, Clerici E, Bellu L, Cappellini LA, Grimaldi M, Pancetti S, Bono B, Franzini A, Riva M, Fernandez B, Niyazi M, Pessina F, Minniti G, Navarria P, Scorsetti M, Politi LS. AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: Analysis of 124 histologically assessed lesions. Neuro Oncol. 2025 Nov 01; 27(11):3029-3039.

View in: PubMed
Mateos MK, Ajuyah P, Fuentes-Bolanos N, El-Kamand S, Barahona P, Altekoester AK, Mayoh C, Holliday H, Liu J, Cui L, Pfaff E, Mackay A, Resnick AC, Pinese M, Lau LMS, Khuong-Quang DA, Dias K, Goudie C, Salkeld A, Rokita JL, Jones DTW, Juretic N, Hayden E, Pfister SM, Kramm CM, Blattner-Johnson M, Jabado N, Tsoli M, Vittorio O, Mueller S, Guo Y, Tucker K, Waszak SM, Perreault S, Jones C, Wong-Erasmus M, Cowley MJ, Ziegler DS. Germline analysis of an international cohort of pediatric diffuse midline glioma patients. Neuro Oncol. 2025 Sep 08; 27(7):1849-1863.

View in: PubMed
Bono BC, Grimi A, Di Toro AE, Ninatti G, Franzini A, Rossini Z, Tropeano MP, Navarria P, Bellu L, Simonelli M, Dipasquale A, Savini G, Levi R, Politi LS, Pessina F, Riva M. Preoperative Diffusion Tensor Imaging and Neurite Dispersion and Density Imaging in Isocitrate Dehydrogenase-Mutant Grade 2 and 3 Gliomas: Definition of Tumor-Related Epilepsy and Predictive Factors of Seizure Outcomes Based on a Single-Center Retrospective Case Series. Neurosurgery. 2025 Jan 29; 97(2):361-373.

View in: PubMed
Bowers DC, Johnson MD. Feasibility of transcranial Doppler to evaluate vasculopathy among survivors of childhood brain tumors exposed to cranial radiation therapy. Pediatr Blood Cancer. 2025 Jan; 72(1):e31392.

View in: PubMed

People

Explore

Similar Concepts

Top Journals